Skip to main content
. 2024 Nov 19;36(3):e47. doi: 10.3802/jgo.2025.36.e47

Table 1. Participant characteristics.

Characteristics Patient (n=154) Physician (n=153) Nurse (n=166) Pharmacist (n=154)
Cancer type
Endometrial cancer 77 (50.0)
Ovarian/fallopian tube cancer 77 (50.0)
Age (yr) 52.9±9.8
History of medical treatment
<3 mo 15 (9.7)
≥3 to <6 mo 50 (32.5)
≥6 to <1 yr 47 (30.5)
≥1 to <1.5 yr 14 (9.1)
≥1.5 to <2 yr 11 (7.1)
≥2 to <3 yr 4 (2.6)
≥3 yr 13 (8.4)
Chemotherapy
Preoperative/postoperative chemotherapy 106 (68.8)
Combination chemotherapy after recurrence 59 (38.3)
Single-agent chemotherapy after recurrence 24 (15.6)
Surgery 100 (64.9)
Radiotherapy 8 (5.2)
Male 118 (77.1) 19 (11.4) 126 (81.8)
Hospital department
Gynecology/Obstetrics & Gynecology 105 (68.6) - -
Oncology 36 (23.5) - -
Radiology/others 12 (7.9) - -
Institution
University hospital 45 (29.4) 43 (25.9) 35 (22.7)
Cancer center 9 (5.9) 11 (6.6) 8 (5.2)
General hospital 50 (32.7) 60 (36.1) 59 (38.3)
National hospitals/public hospitals* 37 (24.2) 49 (29.5) 52 (33.8)
Clinic 12 (7.8) 3 (1.8) 0 (0)
Years of experience (gynecologic cancers)
1 to 4 yr - 2.4 1.3
5 to 10 yr 30.1 11.4 33.1
11 to 20 yr 30.7 55.4 59.8
21 to 30 yr 23.5 28.9 5.8
>30 yr 4.6 0.6 0

Values are presented as number (%), mean ± standard deviation or percentage.

*National Hospital Organization/prefectural/municipal/workers’ compensation hospitals.